Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
May 14, 2026
Reporting period
Not applicable
Filed with the SEC
May 15, 2026
DirectorGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001628280-26-035664
Filed / recorded
May 15, 2026, 8:39 PM UTC
Added to OQRO
Oct 8, 2026, 1:28 AM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
TriSalus Life Sciences, Inc.
Issuer CIK
1826667
Ticker
TLSI
Reporting person
David J Matlin
Relationship
Director
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
May 14, 2026
Transaction code
A
Shares / units
23,065
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
1,323,210
Ownership form
Direct
Amendment
No
Footnotes from the filing
Represents grant of restricted stock units (the "Retainer RSU Award") payable solely in common stock of the Issuer. The Reporting Person elected to receive the Retainer RSU Award in lieu of 2026 board service retainer cash fees provided for under the Issuer's Non-Employee Director Compensation Policy. The shares subject to the Retainer RSU Award shall vest quarterly in equal one-third installments through the remainder of 2026, subject to the Reporting Person's continued service with the Issuer.
A Trisalus Life Sciences director paid $25K out of pocket for Trisalus Life Sciences shares. 4 other people at Trisalus Life Sciences bought some too, in the same month. Shares held went up 16% with this purchase.
The CEO of Trisalus Life Sciences paid $103K out of pocket for Trisalus Life Sciences shares. 4 other people at Trisalus Life Sciences bought some too, in the same month.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.